Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Feature | Julie McLaughlin, Senior Analyst, Millennium Research Group

Transcatheter aortic valve repair (TAVR) — also commonly referred to as transcatheter aortic valve implantation (TAVI) — ...

Home November 22, 2011
Home
News

November 22, 2011 — The thoracic aorta can pose major problems for endovascular repair when there are tortuous segments ...

Home November 22, 2011
Home
News

November 22, 2011 — The question remains whether patency rates for heparin-bonded polytetrafluoroethylene (PTFE) grafts ...

Home November 22, 2011
Home
Whitepapers | Samir Kapadia, Heart and Vascular Institute Cleveland

Patient History
72-year-old, male patient with previously placed bioprosthetic mitral valve.
 

Diagnosis
Mitral ...

Home November 21, 2011
Home
News

November 18, 2011 – CorMatrix Cardiovascular Inc. announced that the U.S. Food and Drug Administration (FDA) has granted ...

Home November 18, 2011
Home
News

November 18, 2011 – Boston Scientific’s Watchman left atrial appendage (LAA) closure device has been implanted in the ...

Home November 18, 2011
Home
Technology

November 18, 2011 – W. L. Gore & Associates Inc. announced that it has received approval from the U.S. Food and Drug ...

Home November 18, 2011
Home
News

November 18, 2011 —The Berlin Heart Group announced today that clinical trial data were presented this morning at the ...

Home November 18, 2011
Home
Feature | Dave Fornell

Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for ...

Home November 17, 2011
Home
News

November 16, 2011 — Heart failure patients with a previous myocardial infarction showed an average of 12 percent ...

Home November 16, 2011
Home
News

November 16, 2011 – Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to ...

Home November 16, 2011
Home
News

November 15, 2011 — A two-year study of patients in the landmark PARTNER trial confirms the one-year findings and ...

Home November 15, 2011
Home
News

 

November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement ...

Home November 15, 2011
Home
News

November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost ...

Home November 14, 2011
Home
Technology

November 11, 2011 — Maquet Cardiovascular announced U.S. Food and Drug Administration (FDA) 510(k) clearance and CE mark ...

Home November 11, 2011
Home
Subscribe Now